{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:06:55Z","timestamp":1792415215035,"version":"4.4.0"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Adenosquamous cell carcinoma (ASC) is a rare and aggressive malignant tumor which consists of both adenocarcinoma (AC) and squamous cell carcinoma (SCC) component types. Although ASC can sometimes develop in the stomach, pancreas, gallbladder and thyroid, it rarely occurs in the liver. As such, primary ASC of the liver remains a poorly understood malignancy due to both the paucity of reported cases and scarcity of available published data. As such, while the use of immune checkpoint inhibitors (ICIs), including PD-1 and PD-L1 antagonists, has profoundly changed the treatment paradigm and outcomes in most tumors, there is virtually no previous documentation for the application of ICIs in the treatment of primary hepatic adenosquamous carcinoma. Herein, we report a clinical case of a 54-year-old woman with metachronous double primary tumors, one of which was dMMR ASC of the liver and received 8 cycles of single-agent immunotherapy using sintilimab. The post-treatment response was evaluated as a pathological complete response (pCR).<\/jats:p>","DOI":"10.3389\/fimmu.2025.1578368","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T05:41:03Z","timestamp":1745991663000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Use of sintilimab in primary adenosquamous carcinoma of the liver results in pathological complete response: a case report and literature review"],"prefix":"10.3389","volume":"16","author":[{"given":"Zhiqing","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ann","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canhong","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2016.0077","article-title":"Primary adenosquamous carcinoma of the liver: A case report","volume":"22","author":"Nam","year":"2016","journal-title":"Clin Mol Hepatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2012.18.3.326","article-title":"Adenosquamous carcinoma of the liver","volume":"18","author":"Park","year":"2012","journal-title":"Clin Mol Hepatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.621594","article-title":"Treatment and survival patterns of primary adenosquamous carcinoma of the liver: A retrospective analysis","volume":"11","author":"Gou","year":"2021","journal-title":"Front Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2019.1654303","article-title":"Durable blockade of pd-1 signaling links preclinical efficacy of sintilimab to its clinical benefit","volume":"11","author":"Wang","year":"2019","journal-title":"mAbs"},{"key":"B5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s40364-020-00250-z","article-title":"Recent updates on sintilimab in solid tumor immunotherapy","volume":"8","author":"Liu","year":"2020","journal-title":"Biomark Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1186\/s12885-023-11188-4","article-title":"Sintilimab plus nab-paclitaxel as second-line treatment for advanced biliary tract cancer: Study protocol for an investigator-initiated phase 2 trial (Napasinti trial)","volume":"23","author":"Zhou","year":"2023","journal-title":"BMC Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/s41467-023-37030-w","article-title":"Clinical and biomarker analyses of sintilimab plus gemcitabine and cisplatin as first-line treatment for patients with advanced biliary tract cancer","volume":"14","author":"Zeng","year":"2023","journal-title":"Nat Commun"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.34372","article-title":"Feasibility and tolerability of sintilimab plus anlotinib as the second-line therapy for patients with advanced biliary tract cancers: an open-label, single-arm, phase ii clinical trial","volume":"152","author":"Jin","year":"2023","journal-title":"Int J Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-002-6585-0","article-title":"Adenosquamous carcinoma of the liver: Clinicopathologic study of 10 surgically treated cases","volume":"27","author":"Yeh","year":"2003","journal-title":"World J Surg"},{"key":"B10","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1007\/s00535-022-01920-5","article-title":"The epidemiology of rare types of hepatobiliary and pancreatic cancer from national cancer registry","volume":"57","author":"Satake","year":"2022","journal-title":"J Gastroenterol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2020.1832571","article-title":"Adenosquamous carcinoma of the digestive system: A literature review","volume":"55","author":"Li","year":"2020","journal-title":"Scand J Gastroenterol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/bf02936966","article-title":"Primary adenosquamous carcinoma of liver resected by right trisegmentectomy: Report of a case and review of the literature","volume":"32","author":"Takahashi","year":"1997","journal-title":"J Gastroenterol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/BF01222246","article-title":"Adenosquamous carcinoma of the liver: Case report","volume":"1","author":"Sasaki","year":"1994","journal-title":"J Bepato-Biliary-Pancreatic Surg"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15708","article-title":"Adenosquamous carcinoma of the liver: the challenge of diagnosis","volume":"43","author":"Liu","year":"2023","journal-title":"Liver Int"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/kjm2.12252","article-title":"Primary adenosquamous carcinoma of the liver","volume":"36","author":"Zhou","year":"2020","journal-title":"Kaohsiung J Med Sci"},{"key":"B16","article-title":"Primary adenosquamous carcinoma of the liver: A case report and review of the literature","volume":"8","author":"Gao","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1186\/s12876-021-02070-3","article-title":"Unresectable primary hepatic adenosquamous carcinoma successfully treated with systemic and transcatheter hepatic arterial injection chemotherapies followed by conversion surgery: A case report and literature review","volume":"21","author":"Watanabe","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.40.631","article-title":"Primary adenosquamous carcinoma of the liver which produces granulocyte-colony-stimulating factor and parathyroid hormone related protein: Association with leukocytosis and hypercalcemia","volume":"40","author":"Hayashi","year":"2001","journal-title":"Internal Med (Tokyo JP)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s12328-021-01474-8","article-title":"Advanced primary adenosquamous carcinoma of the liver with a small cell carcinoma component: an autopsy case report","volume":"14","author":"Nosaka","year":"2021","journal-title":"Clin J Gastroenterol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s005340200108","article-title":"Primary adenosquamous carcinoma of the liver: Case report","volume":"9","author":"Suzuki","year":"2002","journal-title":"J hepato-biliary-pancreatic Surg"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2001.16.4.270","article-title":"A case of primary adenosquamous carcinoma of the liver presented with liver abscess","volume":"16","author":"Kwon","year":"2001","journal-title":"KR J Internal Med"},{"key":"B22","article-title":"Adenosquamous carcinoma presenting as liver abscess","volume":"53","author":"Yeung","year":"2012","journal-title":"Singapore Med J"},{"key":"B23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.14701\/kjhbps.2013.17.1.38","article-title":"A case of primary adenosquamous carcinoma of the liver","volume":"17","author":"Kang","year":"2013","journal-title":"KR J Hepato-Biliary-Pancreatic Surg"},{"key":"B24","article-title":"a rare case of adenosquamous carcinoma in the liver with hepatolithiasis","volume":"46","author":"Harino","year":"2019","journal-title":"Gan Kagaku Ryoho Cancer Chemo"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.4103\/ijpm.Ijpm_785_18","article-title":"Primary hepatic adenosquamous carcinoma: A rare case report","volume":"64","author":"Wei","year":"2021","journal-title":"Indian J Pathol Microbiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s12328-020-01204-6","article-title":"Primary adenosquamous carcinoma of the liver detected during cancer surveillance in a patient with primary sclerosing cholangitis","volume":"13","author":"Daiku","year":"2020","journal-title":"Clin J Gastroenterol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/kjm2.12227","article-title":"A rare case of primary adenosquamous carcinoma of the liver with gallbladder metastasis","volume":"36","author":"Wu","year":"2020","journal-title":"Kaohsiung J Med Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1259\/bjr\/63282776","article-title":"Case report: Adenosquamous carcinoma of the liver successfully treated with repeated transcatheter arterial infusion chemotherapy (Tace) with degradable starch microspheres","volume":"77","author":"Nakai","year":"2004","journal-title":"Br J Radiol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcg.0000180805.56952.04","article-title":"Primary adenosquamous carcinoma of the liver: Case with the longest survival","volume":"39","author":"Demir","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-012-0346-y","article-title":"Synchronous double cancers of primary hepatic adenosquamous carcinoma and hepatocellular carcinoma: Report of a case","volume":"43","author":"Shimizu","year":"2013","journal-title":"Surg Today"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinimag.2007.01.007","article-title":"Imaging findings in primary adenosquamous carcinoma of the liver: A case report","volume":"31","author":"Yokota","year":"2007","journal-title":"Clin Imaging"},{"key":"B32","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000481236","article-title":"Primary hepatic adenosquamous carcinoma associated with primary sclerosing cholangitis","author":"Yamao","year":"2017","journal-title":"Oncology"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcg.0000165705.74079.fc","article-title":"A clinicopathologic study of primary adenosquamous carcinoma of the liver","volume":"39","author":"Kobayashi","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199712000-00015","article-title":"Clinicopathologic features of resected primary adenosquamous carcinomas of the liver","volume":"25","author":"Isa","year":"1997","journal-title":"J Clin Gastroenterol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jhep.2023.03.010","article-title":"EASL-ILCA clinical practice guidelines on the management of intrahepatic cholangiocarcinoma","volume":"79","author":"Alvaro","year":"2023","journal-title":"J Hepatol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1159\/000522403","article-title":"Liver cancer study group of Japan clinical practice guidelines for intrahepatic cholangiocarcinoma","volume":"11","author":"Kubo","year":"2022","journal-title":"Liver Cancer"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.943066","article-title":"Immune-related rna signature predicts outcome of pd-1 inhibitor-combined gemcis therapy in advanced intrahepatic cholangiocarcinoma","volume":"13","author":"Zeng","year":"2022","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.907055","article-title":"Sintilimab combined with lenvatinib for advanced intrahepatic cholangiocarcinoma in second-line setting-a multi-center observational study","volume":"12","author":"Ding","year":"2022","journal-title":"Front Oncol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02786-7","article-title":"Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: A randomized, controlled, phase 2 trial","volume":"30","author":"Wang","year":"2024","journal-title":"Nat Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000000776","article-title":"Sintilimab plus bevacizumab combined with radiotherapy as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A multicenter, single-arm, phase 2 study","volume":"80","author":"Zhu","year":"2024","journal-title":"Hepatol (Baltimore Md)"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1456343","DOI":"10.3389\/fimmu.2024.1456343","article-title":"Case report: Microsatellite instability-high pancreas adenosquamous carcinoma with postoperative liver metastasis recurrence treated with multimodality therapy achieving complete pathological response","volume":"15","author":"Liu","year":"2024","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1064488","DOI":"10.3389\/fimmu.2022.1064488","article-title":"Case report: Complete response to pembrolizumab in a liver metastatic colon adenocarcinoma patient with a novel likely pathogenic germline msh2 mutation","volume":"13","author":"Xu","year":"2022","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2019.02.007","article-title":"Primary adenosquamous carcinoma in a patient with lynch syndrome","volume":"51","author":"Ching","year":"2019","journal-title":"Pathology"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1177\/1066896916659539","article-title":"Primary colon adenosquamous carcinoma in a patient with lynch syndrome: A new histologic subtype associated with microsatellite instability","volume":"24","author":"Duncan","year":"2016","journal-title":"Int J Surg Pathol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.538328","article-title":"Case report: Trastuzumab treatment in adenosquamous carcinoma of the extrahepatic biliary tract with her-2 amplification","volume":"11","author":"Hong","year":"2021","journal-title":"Front Oncol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1578368\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T05:41:04Z","timestamp":1745991664000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1578368\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":45,"alternative-id":["10.3389\/fimmu.2025.1578368"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1578368","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"article-number":"1578368"}}